The global Pneumatic Nebulizers Market size is
anticipated to reach USD 1.02 billion by 2028, registering a CAGR of 6.0% over
the forecast period, according to a new report by Grand View Research, Inc. The
market has shown constant growth in the adoption of pneumatic nebulizers as home
healthcare devices have been gaining popularity in recent years.
Miniaturization of products and technological advancements are also boosting
the adoption of home healthcare devices.
As per the Minnesota Department of Health,
administration of medication through nebulizer represents a lower infection
risk as compared to other aerosol-producing procedures. On the other hand,
according to ISAM, aerosols from the nebulizer do not carry viral particles
derived from the patient as they are generated from the fluid in the nebulized
chamber, which is a non-patient source. Aerosols generated by nebulizers
comprise pathogens only when the healthcare workers or patients contaminate the
nebulizers. Various recommendations from institutes do not clarify whether it is
appropriate to use nebulizers during the pandemic.
However, there are no known cases of passive infection
due to nebulizers. Also, the risk of infection, if any, can be avoided if
proper COVID-19 precautions are taken. Therefore, the pandemic affected the
overall market only to a certain extent. Revolutionary technological progress
is rapidly transforming the market. These expansions are producing lucrative
potentials. For instance, in March 2019, Breath Technologies announced the
initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of
bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI
Pharma that is under investigation.
Related Press Release@ Pneumatic Nebulizers Market Report
Pneumatic Nebulizers Market
Report Highlights
- The breath-actuated product segment held the dominant revenue share
of the global market in 2020 owing to the increased product demand
- The hospitals & clinics end-use segment led the market in 2020
with a revenue share of more than 66% owing to the high product usage a
hospitals & clinics
- In 2020, North America was the dominant regional market owing to
the increased prevalence of respiratory diseases and high product adoption
- Europe accounted for the second-largest revenue share in 2020 due
to increased geriatric population and awareness about the product
- Asia Pacific region is expected to register the fastest CAGR over
the forecast period owing to the presence of emerging countries, such as
China and India
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business
decisions, the company offers market intelligence studies ensuring relevant and
fact-based research across a range of industries including technology,
chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment